LOADING
Comparing Visa Inc (V) and Merck & Company (MRK) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | V | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $692.7B | $376.4B |
| P/E Ratio | 31.1 | 119.2 |
| Forward P/E | 24.3 | 54.0 |
| PEG Ratio | 1.66 | 14.26 |
| EPS | $11.91 | $1.28 |
| Revenue Growth (YoY) | 14.4% | 5.1% |
| Profit Margin | 50.8% | 4.8% |
| Return on Equity | 61.2% | 7.0% |
| Dividend Yield | 0.73% | 2.23% |
| Beta | 0.76 | 0.21 |
| 52-Week High | $373.28 | $154.49 |
| 52-Week Low | $292.74 | $75.81 |
| Volume | -- | -- |
Visa Inc is the larger company by market capitalization. Visa Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.